1941TiP Neoadjuvant pembrolizumab in high-risk thyroid cancer (NePenTHe)

Autor: Leli, C., De Cecco, L., Alfieri, S., Benazzo, M., Durante, C., Raffaelli, M., Locati, L.D.
Zdroj: In Annals of Oncology September 2024 35 Supplement 2:S1126-S1126
Databáze: ScienceDirect